BioSpace News Archive

Business

Epigenomics AG terminates collaboration with Chinese licensing partner and announces anticipated revenue growth in 2019 outlook

Epigenomics AG today has decided to terminate its collaboration with its Chinese partner BioChain for the licensing of the Septin9 marker and the exclusive distribution rights in China for Epi proColon

March 7, 2019
·
2 min read
Drug Development

Allergan’s Depression Treatment Will Not Hit Endpoints in Late-Stage Trial

The company said rapastinel will not likely hit primary and secondary endpoints in three acute studies based on data from an interim analysis.

March 7, 2019
·
2 min read
·
Alex Keown
Drug Development

Alex Trebek’s Pancreatic Cancer Diagnoses Focuses Attention on the Tough-to-Treat Disease

Alex Trebek, 78, host of TV game show “Jeopardy” announced yesterday that he had been diagnosed with stage 4 pancreatic cancer.

March 7, 2019
·
4 min read
·
Mark Terry
Job Trends

BioSpace Movers and Shakers: March 8

Perhaps the biggest mover and shaker announcement this week was the unexpected resignation of Scott Gottlieb, commissioner of the U.S. Food and Drug Administration. Gottlieb will leave his post later this month to spend more time with his family.

March 7, 2019
·
5 min read
·
Alex Keown
First-in-Human Results of SynGEM Demonstrate that the RSV Vaccine Is Well-Tolerated and Capable of Inducing Long-Lasting Immune Responses

SynGEM a needle-free nasal spray vaccine against respiratory syncytial virus

March 7, 2019
·
6 min read
Business

Who Will Replace Scott Gottlieb as Head of the FDA?

Gottlieb announced his intention to leave the FDA earlier this week. The Trump administration will have a list of candidates to choose from as it moves forward.

March 7, 2019
·
3 min read
·
Alex Keown
Business

The Amazon, Berkshire Hathaway, JP Morgan Chase Healthcare Joint Venture Now Named Haven

For more than a year, it had no name other than “ABC,” the first letters of each company’s name. Now, more than a year later, the endeavor has an official name, Haven.

March 7, 2019
·
3 min read
·
Mark Terry
Business

Assertio Therapeutics Announces Fourth-quarter and Full-year 2018 Financial Results

Reports Neurology Franchise Annual Net Sales of $110.3 million, at the High End of Guidance Range

March 7, 2019
·
21 min read
Deals

Oncternal and GTx to Merge, Form New Company Based in San Diego

No employees of GTx are expected to remain with the new company once the merger is complete. Oncternal will begin to trade on the Nasdaq under the ticker symbol ONCT.

March 7, 2019
·
2 min read
·
Alex Keown
Drug Development

Atara Biotherapeutics’ Cancer Drug Might—Might!—Have Applications for MS

This year could be the big year for the company. Its chief executive officer and president, Isaac Ciechanover, is leaving the company by June 30, but says 2019 could be transformative.

March 7, 2019
·
3 min read
·
Mark Terry